Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease

Thrombosis Research

Volumn 120, Issue 2, 2007, Pages 245-250

  Tavil, Yusuf ^a   Sen, Nihat ^a   Yazici, Hüseyin Uǧur ^a   Hizal, Fatma ^a   Abaci, Adnan ^a   Cengel, Atiye ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Coronary artery disease; Mean platelet volume; Metabolic syndrome

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE VOLUME; VASCULAR LESION;

BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL SIZE; CORONARY ARTERIOSCLEROSIS; FEMALE; HEMATOLOGIC TESTS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 34248571463     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.10.005     Document Type: Article

References (32)

1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. Despres J.P., Lamarche B., and Mauriege P. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334 (1996) 952-957
3. Nieuwdorp M., Stroes E.S.G., Meijers J.C.M., and Büller H. Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 5 (2005) 155-159
4. Tsiara S., Elisaf M., Jagroop I.A., and Mikhailidis D.P. Platelets as predictors of vascular risk: is there a practical index of platelet activity?. Clin Appl Thromb Hemost 9 (2003) 177-190
5. Broadley A.J., Gapper P., Schmitt M., and Frenneaux M.P. Supine rest reduces platelet activation and aggregation. Platelets 14 (2003) 3-7
6. Pizzulli L., Yang A., Martin J.F., and Luderitz B. Changes in platelet size and count in unstable angina compared tostable angina or non-cardiac chest pain. Eur Heart J 19 (1998) 80-84
7. Jagroop I.A., and Mikhailidis D.P. Mean platelet volume isan independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 120 1 (2003) 169-170
8. Bath P.M., and Butterworth R.J. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7 (1996) 157-161
9. Coban E., Bostan F., and Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 17 (2006) 67-69
10. Hekimsoy Z., Payzin B., Ornek T., and Kandogan G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications 18 (2004) 173-176
11. Brown A.S., Hong Y., de Belder A., Beacon H., Beeso J., Sherwood R., et al. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 17 (1997) 802-807
12. Sharpe P.C., and Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 86 (1993) 739-742
13. Nadar S.K., Blann A.D., Kamath S., Beevers D.G., and Lip G.Y. Platelet indexes in relation to target organ damage in high-risk hypertensive patients. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 44 (2004) 415-422
14. Coban E., Ozdogan M., Yazci{dotless}oglu G., and Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 59 8 (Aug 2005) 981-982
15. Joint National Committee. The seventh report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC 7). J Am Med Assoc 289 (2003) 2560-2572
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
17. Zeller M., Steg P.G., Ravisy J., Laurent Y., Janin-Manificat L., L'Huillier I., et al. Observatoire des Infarctus de Cote-d'Or SurveyWorking Group. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 165 (2005) 1192-1198
18. Thaulow E., Erikssen J., Sandvik L., Stormorken H., and Cohn P.F. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84 (1991) 613-617
19. Thompson C.B., and Jakubowski J.A. The pathophysiology and clinical relevance of platelet heterogeneity. Blood 72 (1998) 1-8
20. Martin J.F., Trowbridge E.A., Salmon G., and Plumb J. The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32 (1983) 443-460
21. Sewell R., Ibbotson R.M., and Philips R. High mean platelet volume after myocardial infarction: is it due to consumption of small platelets?. Br Med J 289 (1984) 1576-1580
22. Erhart S., Beer J.H., and Reinhart W.H. Influence of aspirin on platelet count and volume in humans. Acta Haematol 101 (1999) 140-144
23. Rewers M., Zaccaro D., D'Agostino R., Haffner S., Saad M.F., and Selby J.V. Insulin sensitivity, insulinemia, and coronary artery disease: the insulin resistance atherosclerosis study. Diabetes Care 27 (2004) 781-787
24. Kip K.E., Marroquin O.C., Kelley D.E., Johnson B.D., Kelsey S.F., Shaw L.J., et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. Circulation 109 (2004) 706-713
25. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
26. Lim H.S., Blann A.D., and Lip G.Y. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation 109 (2004) 2524-2528
27. Iwase E., Tawata M., Aida K., Ozaki Y., Kume S., Satoh K., et al. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism 47 (1998) 699-705
28. Davi G., Catalano I., Averna M., Notarbartolo A., Strano A., Ciabattoni G., et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322 (1990) 1769-1774
29. Keating F.K., Sobel B.E., and Schneider D.J. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol 92 (2003) 1362-1365
30. Honing M.L., Morrison P.J., Banga J.D., Stroes E.S., and Rabelink T.J. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 14 (1998) 241-249
31. Haubelt H., Simon M., Anders Ch., and Hellstern P. Platelet function tests for monitoring of acetylsalicylic acid: clinical significance in antiplatelet treatment. Hamostaseologie 24 3 (2004) 196-202
32. Gensini G.G., and Kelly A.E. Reassessment of contrast agent for coronary angiography. Curr Ther Res Clin Exp 19 (1976) 631-636